SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-126922
Filing Date
2023-12-18
Accepted
2023-12-18 16:54:05
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 tm2333087-1_s3.htm S-3 631919
2 EXHIBIT 4.15 tm2333087d2_ex4-15.htm EX-4.15 303757
3 EXHIBIT 5.1 tm2333087d2_ex5-1.htm EX-5.1 20622
4 EXHIBIT 5.2 tm2333087d2_ex5-2.htm EX-5.2 36510
5 EXHIBIT 23.1 tm2333087d2_ex23-1.htm EX-23.1 2065
6 EX-FILING FEES tm2333087d2_ex-filingfees.htm EX-FILING FEES 62912
7 GRAPHIC lg_seelostherapeutics-4clr.jpg GRAPHIC 13524
8 GRAPHIC tm2333087d2_ex5-1img001.jpg GRAPHIC 4282
9 GRAPHIC tm2333087d2_ex5-2img001.jpg GRAPHIC 4191
10 GRAPHIC tm2333087d2_ex5-2img002.jpg GRAPHIC 4882
  Complete submission text file 0001104659-23-126922.txt   1096693
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276119 | Film No.: 231494476
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)